Jun 1, 2026, 09:50 by

Pfizer and Innovent Biologics have formed a major oncology partnership worth up to $10.5 billion to develop 12 cancer treatment programs, including antibody-drug conjugates (ADCs) and multispecific antibodies. Pfizer will pay $650 million upfront, with additional milestone-based payments tied to development and commercialization progress. The collaboration combines Innovent’s early-stage research capabilities with Pfizer’s global development and commercialization expertise, aiming to accelerate the delivery of innovative cancer therapies worldwide.

Jun 1, 2026, 09:50 by

DNAnexus signals a bold new chapter in AI-powered precision health with several new product innovations and solution packages that extend its position as the purpose-built platform where the world's most scientifically complex data becomes the world's most powerful AI fuel.

Jun 1, 2026, 09:50 by

Quarterly revenue growth up 135% year-on-year, with total revenues passing ₹2000 crore for the first time

Jun 1, 2026, 09:50 by

CellCarta and Leica Biosystems have announced a strategic partnership to bring a proven companion diagnostic (CDx) joint development model from China to biopharma sponsors globally.

May 29, 2026, 01:00 by User Not Found

Clinical Research News | uMotif launches its new Scientific Consulting Services; Veeva Systems announces Veeva Falcon; b.well Connected Health and myTomorrows announce a partnership; and more.

May 27, 2026, 09:42 by

Kivo, the unified document and process management system for life sciences teams, announced today that Chris Xistris has joined the company as Vice President of Services.

May 27, 2026, 09:42 by

Life Sciences Industry Veteran Appointed to Lead Global Commercial Organization

May 27, 2026, 01:00 by User Not Found

Clinical Research News | The Food and Drug Administration is undergoing a major step change in how it regulates and evaluates drugs, marked by a shift toward real-time clinical trials, an agency-wide rollout of generative AI tools to speed up drug application reviews, and a radical transparency push that includes public disclosure of complete response letters sent to pharmaceutical companies explaining why a drug application was rejected.

May 26, 2026, 08:16 by

May 26, 2026, 01:02 by User Not Found

Clinical Research News | Isomorphic Labs continues to develop its AI drug design engine; CellCentric advances in multiple myeloma; and more.

May 21, 2026, 07:44 by

Enhanced pharmacogenetic workflow includes additional variants to support safer, personalised chemotherapy treatment for cancer patients

May 21, 2026, 07:44 by

New open architecture connects AI agents, regulated workflows, and human-authenticated action to Kivo’s GxP-compliant platform.

May 21, 2026, 01:01 by User Not Found

Clinical Research News | High-impact opportunities for leveraging AI across the pharmaceutical R&D cycle are too numerous to count but won’t “automagically” solve any of the longstanding problems in ushering molecules to market. AI requires human attention to match tools to tasks for ensuring the accuracy of model predictions, and the pitfalls are dangerously easy to miss, according to a Novo Nordisk presentation at this week’s Scope X conference in Boston.

May 20, 2026, 07:16 by

Atrandi announced the appointments of Sam Ropp as Chief Commercial Officer and Susan Tousi as Chairman of the Board. These additions strengthen Atrandi’s leadership team as the company accelerates global adoption of its single-cell multiomic SPC technology.

May 20, 2026, 07:16 by

Epigenica AB has announced an agreement with the National Genomics Infrastructure, one of the largest technical platforms at SciLifeLab.

May 20, 2026, 01:01 by User Not Found

Clinical Research News | How cancer patients will respond to treatment can be anticipated based on their genetics as well as the tumor microenvironment, although one relevant component is often all but dismissed: the tumor microbiota. This is despite an abundance of evidence that a cancer’s microbial community plays a major role not only in therapeutic effects but also in tumor development, progression, and metastasis formation.

May 19, 2026, 07:28 by

Medix Biochemica has announced a Board-approved $5 million investment to expand its recombinant antigen and cell culture technology capabilities across its Espoo, Finland and St. Louis, Missouri facilities.

May 19, 2026, 01:01 by User Not Found

Clinical Research News | Earlier this month, TransCelerate BioPharma released a summary report focused on selective safety data collection (SSDC) gathered during a joint tabletop exercise convened in late 2025 in collaboration with U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) Center for Clinical Trial Innovation (C3TI).

May 14, 2026, 10:35 by

Signant Health, the evidence generation company, today announced its acquisition of Ametris (formerly ActiGraph), a global digital health solutions provider.

May 13, 2026, 01:00 by User Not Found

Clinical Research News | An engaged research cohort of over 11 million genotyped individuals has enabled 23andMe to produce a library of more than 300 peer-reviewed publications over the past 16 years. Following a 2025 bankruptcy filing, when it reemerged as a nonprofit medical research organization, the focus has settled on providing individuals with access to their genetic information, supporting genetics education, and studies that provide a deeper understanding of human genetics.